Norman Kong

5.5k total citations · 1 hit paper
11 papers, 4.4k citations indexed

About

Norman Kong is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Norman Kong has authored 11 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Norman Kong's work include Asymmetric Synthesis and Catalysis (5 papers), Cyclopropane Reaction Mechanisms (5 papers) and Catalytic Alkyne Reactions (3 papers). Norman Kong is often cited by papers focused on Asymmetric Synthesis and Catalysis (5 papers), Cyclopropane Reaction Mechanisms (5 papers) and Catalytic Alkyne Reactions (3 papers). Norman Kong collaborates with scholars based in United States, China and Germany. Norman Kong's co-authors include Frank Podlaski, Nader Fotouhi, Emily A. Liu, Christine Lukacs, Christian Klein, Zoran Filipovic, U. Kammlott, Bradford Graves, Daisy Carvajal and Binh Thanh Vu and has published in prestigious journals such as Science, Journal of the American Chemical Society and Cancer Research.

In The Last Decade

Norman Kong

11 papers receiving 4.3k citations

Hit Papers

In Vivo Activation of the p53 Pathway by Small-Molecule A... 2004 2026 2011 2018 2004 1000 2.0k 3.0k

Peers

Norman Kong
U. Kammlott United States
Christine Lukacs United States
Emily A. Liu United States
Zoran Filipovic United States
Sanjeev Shangary United States
Christian Tovar United States
Joan M. Carboni United States
Peter Traxler Switzerland
David Heimbrook United States
U. Kammlott United States
Norman Kong
Citations per year, relative to Norman Kong Norman Kong (= 1×) peers U. Kammlott

Countries citing papers authored by Norman Kong

Since Specialization
Citations

This map shows the geographic impact of Norman Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Kong more than expected).

Fields of papers citing papers by Norman Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Kong. The network helps show where Norman Kong may publish in the future.

Co-authorship network of co-authors of Norman Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Norman Kong. A scholar is included among the top collaborators of Norman Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman Kong. Norman Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Yang, Heping, et al.. (2015). Abstract 3655: Discovery of SC10914: a highly potent, selective and orally active PARP inhibitor for the treatment of BRCA1/2 deficient cancer. Cancer Research. 75(15_Supplement). 3655–3655. 1 indexed citations
3.
Daouti, Sherif, Huisheng Wang, Wenhui Li, et al.. (2009). Characterization of a Novel Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor with a Unique Mechanism of Action for Cancer Therapy. Cancer Research. 69(5). 1924–1932. 25 indexed citations
4.
Vassilev, Lyubomir T., Binh Thanh Vu, Bradford Graves, et al.. (2004). In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2. Science. 303(5659). 844–848. 3722 indexed citations breakdown →
5.
Davies, Huw M. L., Pingda Ren, Norman Kong, Tammy Sexton, & Steven R. Childers. (2002). Synthesis of iodinated 3β-aryltropanes with selective binding to either the dopamine or serotonin transporters. Bioorganic & Medicinal Chemistry Letters. 12(6). 845–847. 4 indexed citations
6.
Davies, Huw M. L., Pingda Ren, Norman Kong, Tammy Sexton, & Steven R. Childers. (2001). Synthesis and monoamine transporter affinity of 3β-(4-(2-pyrrolyl)phenyl)-8-azabicyclo[3.2.1]octanes and 3β-(5-Indolyl)-8-azabicyclo[3.2.1]octanes. Bioorganic & Medicinal Chemistry Letters. 11(4). 487–489. 6 indexed citations
7.
Davies, Huw M. L., Bangping Xiang, Norman Kong, & Douglas G. Stafford. (2001). Catalytic Asymmetric Synthesis of Highly Functionalized Cyclopentenes by a [3 + 2] Cycloaddition. Journal of the American Chemical Society. 123(30). 7461–7462. 72 indexed citations
8.
Davies, Huw M. L., Norman Kong, & Melvyn Rowen Churchill. (1998). Asymmetric Synthesis of Cyclopentenes by [3 + 2] Annulations between Vinylcarbenoids and Vinyl Ethers. The Journal of Organic Chemistry. 63(19). 6586–6589. 39 indexed citations
9.
Davies, Huw M. L. & Norman Kong. (1997). Synthesis and evaluation of a novel dirhodium tetraprolinate catalyst containing bridging prolinate ligands. Tetrahedron Letters. 38(24). 4203–4206. 31 indexed citations
10.
Davies, Huw M. L., Julius J. Matasi, L. Mark Hodges, et al.. (1997). Enantioselective Synthesis of Functionalized Tropanes by Rhodium(II) Carboxylate-Catalyzed Decomposition of Vinyldiazomethanes in the Presence of Pyrroles. The Journal of Organic Chemistry. 62(4). 1095–1105. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026